State of Wyoming’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$989K	Buy	103,862 +51,969	+100%	+$404K	0.12%	91
2025 Q4	$405K	Buy	51,893 +14,810	+40%	+$107K	0.04%	509
2025 Q3	$281K	Buy	37,083 +10,433	+39%	+$86.9K	0.03%	727
2025 Q2	$239K	Sell	26,650 -2,732	-9%	-$25.4K	0.03%	792
2025 Q1	$220K	Sell	29,382 -12,921	-31%	-$104K	0.03%	746
2024 Q4	$318K	Sell	42,303 -10,214	-19%	-$77.5K	0.04%	518
2024 Q3	$399K	Buy	52,517 +45,682	+668%	+$347K	0.06%	281
2024 Q2	$42.2K	Sell	6,835 -4,083	-37%	-$22.5K	0.01%	1377
2024 Q1	$55.5K	Buy	10,918 +7,079	+184%	+$39.8K	0.01%	1262
2023 Q4	$23K	Buy	3,839 +481	+14%	+$2.79K	﹤0.01%	1536
2023 Q3	$23.8K	Buy	3,358 +1,128	+51%	+$8.11K	0.01%	1486
2023 Q2	$15.7K	Buy	2,230 +988	+80%	+$7.93K	﹤0.01%	1442
2023 Q1	$10.4K	Sell	1,242 -1,789	-59%	-$17.2K	﹤0.01%	1484
2022 Q4	$34.8K	Buy	+3,031	New	+$37.8K	0.01%	1171
2022 Q3	–	Sell	-1,082	Closed	-$11K	–	1551
2022 Q2	$11K	Buy	1,082 +261	+32%	+$2.69K	0.01%	1621
2022 Q1	$13K	Buy	821 +138	+20%	+$2.21K	0.01%	1560
2021 Q4	$9K	Sell	683 -37	-5%	-$490	﹤0.01%	1680
2021 Q3	$10K	Sell	720 -346	-32%	-$5.46K	0.01%	1024
2021 Q2	$17K	Buy	1,066 +565	+113%	+$7.68K	0.01%	949
2021 Q1	$5K	Buy	+501	New	+$5.17K	0.01%	439